Equibles does not estimate personal net worth.
Get an email with a short summary when Cardiff Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CRDF alertsJames Levine is recorded as CFO at Cardiff Oncology, Inc. (CRDF). The newest filing on record that lists James Levine as CFO at Cardiff Oncology, Inc. (CRDF) is dated April 23, 2026. The proxy statement of Cardiff Oncology, Inc. reports total compensation of $1,545,615 for James Levine in fiscal 2025, including a base salary of $490,000. Disclosed compensation is on record for 5 fiscal years. James Levine has spoken on 1 earnings call across 1 company, most recently for Cardiff Oncology, Inc. on May 2, 2024. Cardiff Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cardiff Oncology, Inc. includes Mani Mohindru (CEO), Mani Mohindru, Ph.D. (CEO), Mark Erlander (CEO) and 7 others.
“Earlier today, we issued a press release summarizing our financial results for the first quarter ending March 31, 2024. You can also find additional information in our Form 10-Q for the first quarter filed with the SEC earlier today.”
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cardiff Oncology, Inc. (CRDF) | CFO | $490,000 | $1,545,615 |
| 2024 | Cardiff Oncology, Inc. (CRDF) | CFO | $471,194 | $1,266,364 |
| 2023 | Cardiff Oncology, Inc. (CRDF) | CFO | $459,236 | $917,719 |
| 2022 | Cardiff Oncology, Inc. (CRDF) | CFO | $440,475 | $959,479 |
| 2021 | Cardiff Oncology, Inc. (CRDF) | CFO | $202,693 | $2,467,695 |
